Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals.
Saved in:
| Title: | Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals. |
|---|---|
| Authors: | Doua J; Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica, Beerse, Belgium., Geurtsen J; Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Rodriguez-Baño J; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.; Department of Medicine, University of Sevilla, Seville, Spain.; Biomedicine Institute of Sevilla/CSIC, Seville, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Cornely OA; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Go O; Janssen Research & Development, Raritan, New Jersey, USA., Gomila-Grange A; Infectious Diseases Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.; Infectious Diseases Department, Hospital Parc Taulí de Sabadell, Parc Tauli, Barcelona, Spain., Kirby A; Leeds Institute of Medical Research, The University of Leeds, Old Medical School, Leeds General Infirmary, Leeds, West Yorkshire, United Kingdom., Hermans P; Julius Center for Health Sciences and Primary Care University Medical Center, Utrecht University, Utrecht, The Netherlands., Gori A; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Zuccaro V; Infectious Diseases Department, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Lombardy, Italy., Gravenstein S; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA., Bonten M; Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands., Poolman J; Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Sarnecki M; Clinical Development, Janssen Vaccines, Bern, Switzerland. |
| Source: | Open forum infectious diseases [Open Forum Infect Dis] 2023 Jan 27; Vol. 10 (2), pp. ofad026. Date of Electronic Publication: 2023 Jan 27 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-8957 |
|---|---|
| DOI: | 10.1093/ofid/ofad026 |
